IV Iron Preparation — Iron Deficiency Anaemia in Pregnancy
Pregnancy: Post 13 weeks — avoid first trimester
Ferric Carboxymaltose (IV Iron — Pregnancy)
Brand names: Ferinject
Adult dose
Dose: Single dose up to 1000 mg IV. Dose based on haemoglobin and body weight (Ferinject dosing table). Standard: 1000 mg IV in 100 mL NaCl 0.9% over 15 min (if weight ≥66 kg and Hb <10 g/dL)
Route: IV infusion
Frequency: Single dose (repeat based on response and Hb)
Max: 1000 mg per single infusion; 1500 mg/week
NICE: IV iron recommended in pregnancy if Hb <100 g/L after 13 weeks, or if oral iron intolerance/malabsorption/non-response. Ferinject does not require a test dose. Administer only in settings with resuscitation facilities. Not licensed in first trimester (data limited).
Paediatric dose
Route: N/A
Frequency: N/A
Max: N/A
Not applicable in obstetric indication; paediatric IV iron — see separate entry
Dose adjustments
Renal
No dose adjustment required
Hepatic
No dose adjustment required
Clinical pearls
- IV iron corrects iron deficiency anaemia faster than oral iron — beneficial in late pregnancy when there is insufficient time for oral response
- Ferinject can be given as a single large dose (up to 1000 mg in 15 min) — much more convenient than older IV iron preparations (iron sucrose required multiple infusions)
- Hypophosphataemia: Ferinject causes transient but sometimes severe hypophosphataemia — check phosphate at 4–6 weeks post-infusion in high-risk patients
- No test dose required for Ferinject (unlike older iron dextran preparations)
- Target Hb: >105 g/L at booking; >110 g/L at 28 weeks (WHO thresholds for iron supplementation in pregnancy)
Contraindications
- First trimester of pregnancy
- Iron overload
- Hypersensitivity to IV iron
- Anaemia not caused by iron deficiency
Side effects
- Hypersensitivity/anaphylaxis (rare — resuscitation facilities required)
- Transient hypophosphataemia (common with Ferinject — check phosphate after large doses)
- Nausea
- Injection site reactions
- Headache
- Hypertension (transient)
Interactions
- Oral iron — do not take simultaneously (IV iron suppresses absorption of oral iron for up to 5 days)
Monitoring
- Haemoglobin and ferritin (4–6 weeks post-infusion)
- Serum phosphate (4–6 weeks, especially in recurrent/large doses)
- Vitals during infusion (anaphylaxis monitoring for 30 min post-dose)
Reference: BNFc; NICE NG25; RCOG Iron Deficiency Anaemia in Pregnancy (2015); BNF; Ferinject SPC. Verify against your local formulary and the latest BNF before prescribing.
Related
Curated clinical cross-links plus same-class fallbacks.
Calculators
- Corrected Reticulocyte Count / Reticulocyte Production Index · Anaemia
- Ganzoni Equation for Iron Deficiency · Anaemia
- Transferrin Saturation Calculator · Anaemia / Iron Studies
- CTCAE Grading for Anaemia · Toxicity Grading
- Iron Deficiency Anaemia Calculator · Anaemia Assessment
- Reticulocyte Production Index (RPI) · Anaemia Assessment
Pathways
- Spinal Anaesthesia Hypotension Management · AAGBI; ASA
- Pre-Eclampsia / Eclampsia in ED · NICE NG133; RCOG Green-top 10A
- Suspected Ectopic Pregnancy · NICE NG126; RCOG Green-top 21
- Polycystic Ovary Syndrome (PCOS) · International PCOS Guideline 2023; NICE CKS
- Pre-eclampsia Management · NICE NG133 2019
- Ectopic Pregnancy · NICE CG154 / RCOG GTG 21